260 related articles for article (PubMed ID: 22846569)
21. Fra-1 promotes breast cancer chemosensitivity by driving cancer stem cells from dormancy.
Lu D; Chen S; Tan X; Li N; Liu C; Li Z; Liu Z; Stupack DG; Reisfeld RA; Xiang R
Cancer Res; 2012 Jul; 72(14):3451-6. PubMed ID: 22586064
[TBL] [Abstract][Full Text] [Related]
22. Let‑7 miRNAs sensitize breast cancer stem cells to radiation‑induced repression through inhibition of the cyclin D1/Akt1/Wnt1 signaling pathway.
Sun H; Ding C; Zhang H; Gao J
Mol Med Rep; 2016 Oct; 14(4):3285-92. PubMed ID: 27574028
[TBL] [Abstract][Full Text] [Related]
23. WNT1 gene expression alters in heterogeneous population of prostate cancer cells; decreased expression pattern observed in CD133+/CD44+ prostate cancer stem cell spheroids.
Goksel G; Bilir A; Uslu R; Akbulut H; Guven U; Oktem G
J BUON; 2014; 19(1):207-14. PubMed ID: 24659666
[TBL] [Abstract][Full Text] [Related]
24. Cancer stemness in Wnt-driven mammary tumorigenesis.
Monteiro J; Gaspar C; Richer W; Franken PF; Sacchetti A; Joosten R; Idali A; Brandao J; Decraene C; Fodde R
Carcinogenesis; 2014 Jan; 35(1):2-13. PubMed ID: 23955540
[TBL] [Abstract][Full Text] [Related]
25. TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.
Czerwińska P; Shah PK; Tomczak K; Klimczak M; Mazurek S; Sozańska B; Biecek P; Korski K; Filas V; Mackiewicz A; Andersen JN; Wiznerowicz M
Oncotarget; 2017 Jan; 8(1):863-882. PubMed ID: 27845900
[TBL] [Abstract][Full Text] [Related]
26. LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.
Yue Z; Yuan Z; Zeng L; Wang Y; Lai L; Li J; Sun P; Xue X; Qi J; Yang Z; Zheng Y; Fang Y; Li D; Siwko S; Li Y; Luo J; Liu M
FASEB J; 2018 May; 32(5):2422-2437. PubMed ID: 29269400
[TBL] [Abstract][Full Text] [Related]
27. FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors.
Paul R; Luo M; Mo X; Lu J; Yeo SK; Guan JL
Breast Cancer Res; 2020 Jun; 22(1):59. PubMed ID: 32493400
[TBL] [Abstract][Full Text] [Related]
28. Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.
Rowehl RA; Crawford H; Dufour A; Ju J; Botchkina GI
Cancer Genomics Proteomics; 2008; 5(6):301-10. PubMed ID: 19287071
[TBL] [Abstract][Full Text] [Related]
29. Establishment of human ovarian serous carcinomas cell lines in serum free media.
Pan Z; Hooley J; Smith DH; Young P; Roberts PE; Mather JP
Methods; 2012 Mar; 56(3):432-9. PubMed ID: 22445873
[TBL] [Abstract][Full Text] [Related]
30. Expansion of breast cancer stem cells with fibrous scaffolds.
Feng S; Duan X; Lo PK; Liu S; Liu X; Chen H; Wang Q
Integr Biol (Camb); 2013 May; 5(5):768-77. PubMed ID: 23529778
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer stem cells: an update.
Iqbal J; Chong PY; Tan PH
J Clin Pathol; 2013 Jun; 66(6):485-90. PubMed ID: 23322821
[TBL] [Abstract][Full Text] [Related]
32. Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.
Yeo SK; French R; Spada F; Clarkson R
Breast Cancer Res Treat; 2017 Apr; 162(3):465-477. PubMed ID: 28190248
[TBL] [Abstract][Full Text] [Related]
33. Eliminating drug resistant breast cancer stem-like cells with combination of simvastatin and gamma-tocotrienol.
Gopalan A; Yu W; Sanders BG; Kline K
Cancer Lett; 2013 Jan; 328(2):285-96. PubMed ID: 23063651
[TBL] [Abstract][Full Text] [Related]
34. Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice.
Watanabe K; Fallahi M; Dai X
Oncogene; 2014 Jan; 33(5):632-42. PubMed ID: 23334328
[TBL] [Abstract][Full Text] [Related]
35. Cellular dormancy in minimal residual disease following targeted therapy.
Ruth JR; Pant DK; Pan TC; Seidel HE; Baksh SC; Keister BA; Singh R; Sterner CJ; Bakewell SJ; Moody SE; Belka GK; Chodosh LA
Breast Cancer Res; 2021 Jun; 23(1):63. PubMed ID: 34088357
[TBL] [Abstract][Full Text] [Related]
36. Control of breast cancer growth and initiation by the stem cell-associated transcription factor TCF3.
Slyper M; Shahar A; Bar-Ziv A; Granit RZ; Hamburger T; Maly B; Peretz T; Ben-Porath I
Cancer Res; 2012 Nov; 72(21):5613-24. PubMed ID: 23090119
[TBL] [Abstract][Full Text] [Related]
37. Tumorigenic lung tumorospheres exhibit stem-like features with significantly increased expression of CD133 and ABCG2.
Zhao W; Luo Y; Li B; Zhang T
Mol Med Rep; 2016 Sep; 14(3):2598-606. PubMed ID: 27432082
[TBL] [Abstract][Full Text] [Related]
38. EMT in breast cancer stem cell generation.
Ansieau S
Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497
[TBL] [Abstract][Full Text] [Related]
39. The noninflammatory role of high mobility group box 1/Toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells.
Conti L; Lanzardo S; Arigoni M; Antonazzo R; Radaelli E; Cantarella D; Calogero RA; Cavallo F
FASEB J; 2013 Dec; 27(12):4731-44. PubMed ID: 23970797
[TBL] [Abstract][Full Text] [Related]
40. Tracking of mouse breast cancer stem-like cells with Salmonella.
Chang WW; Kuan YD; Chen MC; Lin ST; Lee CH
Exp Biol Med (Maywood); 2012 Oct; 237(10):1189-96. PubMed ID: 23045719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
